KA

Kirti Amoolya Vakil

Director Director DIN 08172710
DIN 08172710 First appointment May 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since May 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Kirti Amoolya Vakil

Data last updated:

Kirti Amoolya Vakil has 8 years in corporate governance. Formerly with 1 company, such as Aditi Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 08172710
Primary Designation Director
First Appointment 13 May 2018
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aditi Pharmaceuticals Pvt Ltd U24239PN1985PTC036140
Director13 May 20181985₹14.54 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aditi Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Kirti Amoolya Vakil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kirti Amoolya Vakil

Kirti Amoolya Vakil has 8 years in corporate governance. Formerly with 1 company, such as Aditi Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

Kirti Amoolya Vakil has expertise in General Business.

Kirti Amoolya Vakil has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available